These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 7486597)
1. Clinical potential for the use of neuroprotective agents. A brief overview. Trembly B Ann N Y Acad Sci; 1995 Sep; 765():1-20; discussion 26-7. PubMed ID: 7486597 [TBL] [Abstract][Full Text] [Related]
2. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Di Mascio R; Marchioli R; Tognoni G Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186 [TBL] [Abstract][Full Text] [Related]
3. Update on calcium antagonists in cerebrovascular diseases. Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729 [TBL] [Abstract][Full Text] [Related]
4. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy]. Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133 [TBL] [Abstract][Full Text] [Related]
5. Pharmacology of lazaroids and brain energy metabolism: a review. Villa RF; Gorini A Pharmacol Rev; 1997 Mar; 49(1):99-136. PubMed ID: 9085310 [No Abstract] [Full Text] [Related]
13. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Hall ED; McCall JM; Means ED Adv Pharmacol; 1994; 28():221-68. PubMed ID: 8080818 [No Abstract] [Full Text] [Related]
14. Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage. Tettenborn D; Dycka J; Volberg E; Düdden P Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():84-6. PubMed ID: 4010871 [TBL] [Abstract][Full Text] [Related]
15. Nimodipine Reappraised: An Old Drug With a Future. Carlson AP; Hänggi D; Macdonald RL; Shuttleworth CW Curr Neuropharmacol; 2020; 18(1):65-82. PubMed ID: 31560289 [TBL] [Abstract][Full Text] [Related]
16. The effect and management of delayed vasospasm after aneurysmal subarachnoid hemorrhage. Dorsch NW Neurol Med Chir (Tokyo); 1998; 38 Suppl():156-60. PubMed ID: 10234999 [TBL] [Abstract][Full Text] [Related]
18. Emerging strategies for the treatment of ischemic brain injury. Ginsberg MD Res Publ Assoc Res Nerv Ment Dis; 1993; 71():207-37. PubMed ID: 8417467 [No Abstract] [Full Text] [Related]
19. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review. Adams HP Angiology; 1990 Nov; 41(11 Pt 2):1010-6. PubMed ID: 2248423 [TBL] [Abstract][Full Text] [Related]
20. Is there a need for alternative approaches in the therapy of cerebrovascular disorders? Hartmann A Eur Neurol; 1986; 25 Suppl 1():7-26. PubMed ID: 3758110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]